Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NowPatient vs Nurx

NowPatient
Graded #217

Lower grade

vs+1
Nurx
Graded #185

Higher grade

The verdict

Nurx takes it — 66.5/100 to 65.5/100, but only just.

Nurx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Established women's telehealth brand offering tiered GLP-1 weight loss programs. NowPatient is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNurx +26
35
61
Dose & formulationNowPatient +16
93
77
Clinical oversightNowPatient +7
86
79
Labs & monitoringNowPatient +2
54
52
FulfillmentNowPatient +5
70
65
Contract termsEven
55
55
NowPatient · left barNurx · right bar

The numbers

MetricNowPatientNurx
WeighScore65.5/10066.5/100
GradeCC
Scorecard rank#217#185
Semaglutide$1,349/mo (brand Wegovy)$179/mo (starting dose, compounded)
Tirzepatide$1,069/mo (brand Mounjaro, promotional rate)$179/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualYesInjection only
NowPatient

Graded #217 · C

Strengths

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

Where it loses points

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)
Nurx

Graded #185 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard